CA2205600A1 - Freeze-dried ondansetron compositions - Google Patents

Freeze-dried ondansetron compositions

Info

Publication number
CA2205600A1
CA2205600A1 CA 2205600 CA2205600A CA2205600A1 CA 2205600 A1 CA2205600 A1 CA 2205600A1 CA 2205600 CA2205600 CA 2205600 CA 2205600 A CA2205600 A CA 2205600A CA 2205600 A1 CA2205600 A1 CA 2205600A1
Authority
CA
Canada
Prior art keywords
freeze
compositions
dried
pharmaceutically acceptable
ondansetron compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2205600
Other languages
French (fr)
Other versions
CA2205600C (en
Inventor
Ian Keith Winterborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9423511A external-priority patent/GB9423511D0/en
Application filed by Individual filed Critical Individual
Publication of CA2205600A1 publication Critical patent/CA2205600A1/en
Application granted granted Critical
Publication of CA2205600C publication Critical patent/CA2205600C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

The invention relates to a freeze-dried dosage form for oral administration capable of being rapidly disintegrated in the mouth comprising ondansetron in the form of its free base or a pharmaceutically acceptable solvate thereof and one or more pharmaceutically acceptable excipients. Methods for the manufacture of such compositions and for their use in the treatment of conditions mediated through the action of 5-hydroxytryptamine (5HT) at 5HT3 receptors are also described.
CA 2205600 1994-11-22 1995-11-20 Freeze-dried ondansetron compositions Expired - Lifetime CA2205600C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9423511A GB9423511D0 (en) 1994-11-22 1994-11-22 Compositions
GB9423511.6 1994-11-22
PCT/EP1995/004550 WO1996015785A1 (en) 1994-11-22 1995-11-20 Freeze-dried ondansetron compositions

Publications (2)

Publication Number Publication Date
CA2205600A1 true CA2205600A1 (en) 1996-05-30
CA2205600C CA2205600C (en) 2000-05-30

Family

ID=29421792

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2205600 Expired - Lifetime CA2205600C (en) 1994-11-22 1995-11-20 Freeze-dried ondansetron compositions

Country Status (1)

Country Link
CA (1) CA2205600C (en)

Also Published As

Publication number Publication date
CA2205600C (en) 2000-05-30

Similar Documents

Publication Publication Date Title
GB2295318B (en) Freeze-dried dosage form containing ondansetron
CA2205546A1 (en) Oral compositions containing ondansetron
AP1637A (en) Celecoxib compositions.
CA2362816A1 (en) Valdecoxib compositions
HUP0402178A2 (en) Pharmaceutical composition comprising a 5 hti receptor agonist
CA2180178A1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
CA2135179A1 (en) Pharmaceutical Compositions of Alkylsulphonamides 5HT1 Agonists for Rectal Administration
CA2205600A1 (en) Freeze-dried ondansetron compositions
CA2162919A1 (en) Rectal Compositions
WO2002055062A3 (en) Pharmaceutical tablet comprising paroxetine mesylate

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20151120